Irritable Bowel Syndrome (IBS) Treatment Market Size, Share, Trends Analysis, Industry Top Players And Forecast To 2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2023 identifies rise in the prevalence of irritable bowel syndrome (IBS) as the major driver for the irritable bowel syndrome (IBS) treatment market's growth in the forecast period. IBS is a chronic gastrointestinal disorder affecting the large intestine (colon). The rise in irritable bowel syndrome (IBS) prevalence is driven by poor lifestyles, bad eating habits, exposure to pollution, and increased stress levels. IBS treatment helps to reduce the severity and frequency of IBS symptoms, improve the quality of life, and enable individuals to manage their conditions better.

The global irritable bowel syndrome (IBS) market size is expected to grow from $2.25 billion in 2022 to $2.50 billion in 2023 at a compound annual growth rate (CAGR) of 11.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of irritable bowel syndrome (IBS) market is expected to reach $3.82 billion in 2027 at a CAGR of 11.2%.

Download Free Sample Of Irritable Bowel Syndrome (IBS) Treatment Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=11978&type=smp

Major competitors in the irritable bowel syndrome (IBS) treatment market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Abbott Laboratories.

A key trend in the irritable bowel syndrome (IBS) treatment market includes product innovations. Major irritable bowel syndrome (IBS) market players are concentrating their efforts on creating new and innovative, advanced products to strengthen their position in the market. For instance, in April 2022, Ardelyx, a US-based biotechnology company, launched IBSRELA, a first-in-class treatment for IBS-C in adults. It is the first and only NHE3 inhibitor available for treating adult irritable bowel syndrome with constipation (IBS-C). IBSRELA, the first Ardelyx medicine to receive FDA approval, is the first novel mechanism therapy for IBS-C (irritable bowel syndrome-constipation) to be developed in almost ten years, and it provides a significant new treatment option for constipation, bloating, and stomach pain that are symptoms of this crippling disorder.

Read More On The Global Irritable Bowel Syndrome (IBS) Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/irritable-bowel-syndrome-ibs-treatment-global-market-report

The irritable bowel syndrome (IBS) treatment market is segmented -
1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs

2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

4) By End-Users: Hospitals, Clinics, Homecare Settings

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the irritable bowel syndrome (IBS) treatment market.

The Business Research Company's "Global Irritable Bowel Syndrome (IBS) Treatment Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Irritable Bowel Syndrome (IBS) Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11978

The Table Of Content For The Irritable Bowel Syndrome (IBS) Treatment Market Include:
1. Executive Summary
2. Irritable Bowel Syndrome (IBS) Treatment Market Characteristics
3. Irritable Bowel Syndrome (IBS) Treatment Market Trends And Strategies
4. Irritable Bowel Syndrome (IBS) Treatment Market - Macro Economic Scenario
…….
32. Global Irritable Bowel Syndrome (IBS) Treatment Market Competitive Benchmarking
33. Global Irritable Bowel Syndrome (IBS) Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Irritable Bowel Syndrome (IBS) Treatment Market
35. Irritable Bowel Syndrome (IBS) Treatment Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.